AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FILGRASTIM
35 registrations across 10 African markets— 21 active
Markets with FILGRASTIM
🇹🇳Tunisia
9 registrations
0 active
🇸🇳Senegal
6 registrations
6 active
🇿🇦South Africa
4 registrations
4 active
🇬🇭Ghana
4 registrations
0 active
🇳🇬Nigeria
2 registrations
2 active
🇨🇮Côte d'Ivoire
2 registrations
1 active
🇿🇼Zimbabwe
2 registrations
2 active
🇰🇪Kenya
2 registrations
2 active
🇲🇦Morocco
2 registrations
2 active
🇲🇬Madagascar
2 registrations
2 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ZARZIO 30 MU | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Mar 2030 |
| ZARZIO 48 MU | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Mar 2030 |
| Zarzio 48 MU/0.5 ml Solution For Infusion In Pre-Filled Syringe | 🇰🇪Kenya | Sandoz Pharmaceuticals d.d. Verovskova Ulica 57 | active | Mar 2028 |
| Zarzio 30 MU/0.5 ml Solution For Infusion In Pre-Filled Syringe | 🇰🇪Kenya | Sandoz Pharmaceuticals d.d. Verovskova Ulica 57 | active | Mar 2028 |
| NEUTAS INJECTABLE; INJECTION | 🇿🇼Zimbabwe | INTAS PHARMACEUTICAL LIMITED | active | Dec 2027 |
| ACCOFIL INJECTABLE; INJECTION | 🇿🇼Zimbabwe | FINE PHARMACEUTICALS PVT LTD | active | Dec 2027 |
| Zarzio 48 MU/0.5 mL** Solution for injection/infusion | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Aug 2027 |
| Zarzio 30 MU/0.5 mL** Solution for injection/infusion | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Aug 2027 |
| ZARZIO 30 MU/ 0.5 ML | 🇬🇭Ghana | — | expired | Jul 2026 |
| ZARZIO 48 MU/ 0.5 ML | 🇬🇭Ghana | — | expired | Jul 2026 |
| ZARZIO 48 MU/ 0.5 ML | 🇬🇭Ghana | — | expired | Jul 2026 |
| ZARZIO 30 MU/ 0.5 ML | 🇬🇭Ghana | — | expired | Jul 2026 |
| LEUCOSTIM 300 G SOLUTION INJECTABLE EN SERINGUE PRE-REMPLIE BOITE DE 5 | 🇨🇮Côte d'Ivoire | PHARMACEUTICAL INSTITUTE | expired | Feb 2024 |
| NIVESTIM Solution injectable / 30 MU/0.5 ml | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Jun 2022 |
| NIVESTIM Solution injectable / 48 MU/0.5 ml | 🇹🇳Tunisia | PFIZER Europe MA EEIG | expired | Jun 2022 |
| ACCOFIL Solution injectable / 48 MU | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jun 2017 |
| ACCOFIL Solution injectable / 30 MU | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jun 2017 |
| ZARZIO Solution injectable / 30 MU | 🇹🇳Tunisia | SANDOZ GmbH | expired | Oct 2012 |
| ZARZIO Solution injectable / 48 MU | 🇹🇳Tunisia | SANDOZ GmbH | expired | Oct 2012 |
| NEUTROMAX Solution injectable / 30 MU | 🇹🇳Tunisia | BIO SIDUS S.A | expired | Dec 2011 |
| NEUTROMAX Solution injectable / 48 MU | 🇹🇳Tunisia | BIO SIDUS S.A | expired | Dec 2011 |
| IOR LEUKOCIM Solution injectable / 30 MU/ML | 🇹🇳Tunisia | Center of Molecular Immunology | expired | May 2008 |
| NEUPOGEN 30 MU | 🇿🇦South Africa | Amgen South Africa (Pty)Ltd | active | Jan 1900 |
| NEUPOGEN 48 MU | 🇿🇦South Africa | Amgen South Africa (Pty)Ltd | active | Jan 1900 |
| FILGRASTIM seringue pré remplie / 0,3 mg | 🇸🇳Senegal | AMANYS PHARMA | active | — |
| ACCOFIL solution injectable / 12 MU / 0,2ml | 🇸🇳Senegal | ACCORD | active | — |
| NEUPOGEN SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| FILGRASTI-M SI IV/SC SER PRE BTE (1 SER PRE X 1ML) MULTI-G BVBA solution injectable IV/SC en | 🇲🇬Madagascar | MULTI-G BVBA | active | — |
| FILGRASTI-M SI IV/SC SER PRE BTE (1 SER PRE X 1ML) MULTI-G BVBA solution injectable IV/SC en | 🇲🇬Madagascar | MULTI-G BVBA | active | — |
| NEUPOGEN SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| NEUTROPINE 30 MUI SOLUTION INJECTABLE SC/IV EN SERINGUE PRE-REMPLIE BOITE DE 1 | 🇨🇮Côte d'Ivoire | AMANYS PHARMA PRIVATE LIMITED | active | — |
| NEUTROPINE INJ solution injectable en seringue pre-remplie / 0.3 mg / ml | 🇸🇳Senegal | SAHAM PHARMA | active | — |
| ACCOFIL solution injectable / 30 MU / 0,5ml | 🇸🇳Senegal | ACCORD | active | — |
| ACCOFIL solution injectable / 12 MU / 0,2ml | 🇸🇳Senegal | ACCORD | active | — |
| ACCOFIL solution injectable / 30 MU / 0,5ml | 🇸🇳Senegal | ACCORD | active | — |
FILGRASTIM in Africa — Regulatory Overview
FILGRASTIM is registered across 10 African markets with 35 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Senegal, South Africa, Ghana and 6 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 35 registrations, 21 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.